Clinical Trials Directory

Trials / Completed

CompletedNCT04906564

RNF213 Variants and Collateral Vessels in Moyamoya Disease

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
4 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to detect the association between RNF213 variants and collateral vessels in patients with moyamoya disease.

Detailed description

Moyamoya disease (MMD) is a chronic cerebrovascular disorder characterized by the presence of occlusion which occurs at the internal carotid arteries and their main branches during the development of a basal collateral network. The ring finger 213 (RNF213) was identified as a strong susceptibility gene in patients with MMD in East Asia. The role of RNF213 variants in pathogenesis of MMD is still unclear. Specific "moyamoya vessels" correlate with the onset of stroke. The purpose of this study is to investigate the relationship between RNF213 variants and collateral vessels in patients with moyamoya disease, and provide potential pathogenesis of moyamoya disease.

Conditions

Interventions

TypeNameDescription
OTHERIdentification of genetic variantsIdentification of genetic variants

Timeline

Start date
2019-01-01
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2021-05-28
Last updated
2022-02-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04906564. Inclusion in this directory is not an endorsement.